A Study to Investigate the Effect of Inhaling Single Doses of Different Formulations of GW642444M in Asthmatic Patients

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

April 27, 2008

Primary Completion Date

October 4, 2008

Study Completion Date

October 4, 2008

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG

Placebo

comparator

DRUG

GW642444

investigational drug or placebo

DRUG

Magnesium Stearate

Magnesium Stearate

Trial Locations (3)

3168

GSK Investigational Site, Clayton

4066

GSK Investigational Site, Auchenflower

6035

GSK Investigational Site, Wellington

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY